Study guide

17.3 Adverse Drug Reactions & Hypersensitivity Recognition

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

17.3 Adverse Drug Reactions & Hypersensitivity Recognition

Key Takeaways Explain This Topic AI

Adverse drug reactions are classified as Type A (augmented, dose-related, predictable) or Type B (bizarre, idiosyncratic, not dose-related)

Gell and Coombs hypersensitivity types are I (IgE-mediated, anaphylaxis), II (cytotoxic, haemolysis), III (immune-complex, serum sickness), IV (delayed T-cell, contact dermatitis and SJS/TEN), and V (receptor-mediated)

Penicillin cross-reactivity with cephalosporins is around 1–2% overall and higher with first-generation cephalosporins

Severe cutaneous adverse reactions — SJS, TEN, DRESS — present with mucosal involvement, skin blistering or peeling, and eosinophilia with organ involvement; stop the drug and refer urgently

First-line treatment for anaphylaxis is intramuscular adrenaline (epinephrine) 0.5 mg in the anterolateral thigh for adults

Last updated: August 2026

Adverse Drug Reactions — Type A vs Type B

An adverse drug reaction (ADR) is any noxious, unintended response to a medicine used at normal doses. The Rawlins-Thompson classification divides ADRs into two broad families that the DHA exam tests directly.

  • Feature Type A (Augmented) Type B (Bizarre)
  • Relationship to dose Dose-related, predictable Not dose-related, unpredictable
  • Mechanism Exaggerated normal pharmacological action Idiosyncratic, immunological, genetic
  • Frequency Common Rare

Example Bradycardia from a beta-blocker; bleeding from warfarin; hypoglycaemia from insulin Anaphylaxis to penicillin; agranulocytosis from clozapine; SJS from sulfonamides

Management Adjust dose; often reversible Stop drug immediately; usually not re-challenged

A practical rule: Type A is the drug doing its job too well; Type B is the drug doing something unexpected. Exam stems that describe a reaction at a therapeutic dose with a known pharmacological mechanism point to Type A; stems describing rash, anaphylaxis, or cytopenias in a small number of patients point to Type B.

Gell and Coombs Hypersensitivity Classification

The Gell and Coombs system classifies immunological drug reactions into five types.

Type I — Immediate, IgE-Mediated

Mechanism : drug-IgE cross-linking on mast cells releases histamine and mediators within minutes to hours.

Manifestations : urticaria, angioedema, bronchospasm, anaphylaxis .

Classic drugs : penicillin, cephalosporins, iodinated contrast, latex, some muscle relaxants.

Skin test : prick testing may detect specific IgE.

Type II — Cytotoxic

Mechanism : IgG or IgM binds drug on a cell surface; complement lyses the cell.

Manifestations : haemolytic anaemia (e.g. methyldopa, penicillin high-dose), thrombocytopenia (heparin-induced thrombocytopenia, quinine), neutropenia.

Timing : hours to days.

Type III — Immune-Complex

Mechanism : drug-antibody complexes deposit in tissues and activate complement.

Manifestations : serum sickness — fever, arthralgia, urticarial rash, lymphadenopathy; drug-induced vasculitis; interstitial nephritis.

Classic drugs : penicillin, sulfonamides, antithymocyte globulin.

Timing : 1–3 weeks after exposure.

Type IV — Delayed, T-Cell Mediated

Mechanism : sensitised T-cells react to drug antigen presented in skin or tissue.

Manifestations : contact dermatitis (topical antibiotics, nickel), maculopapular drug rash, and the severe cutaneous adverse reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) .

Timing : 2–14 days.

Classic drugs for SJS/TEN : sulfonamides, allopurinol, anticonvulsants (carbamazepine, lamotrigine, phenytoin), nevirapine, NSAIDs (oxicam class).

Type V — Receptor-Mediated (Anti-Receptor Antibody)

Mechanism : autoantibodies bind and stimulate or block a cell-surface receptor.

Examples : Graves disease (anti-TSH receptor stimulating antibody); myasthenia gravis (anti-AChR blocking antibody). Drug-induced versions are rare but the classification is tested.

Penicillin–Cephalosporin Cross-Reactivity

A frequently tested calculation: the overall cross-reactivity between penicillin and cephalosporins is approximately 1–2% , and is driven mainly by shared side-chain similarity rather than the beta-lactam ring itself. Cross-reactivity is higher with first-generation cephalosporins (e.g. cephalexin, cefazolin) and much lower with third- and fourth-generation agents (e.g. ceftriaxone, cefepime). A patient with a confirmed IgE-mediated penicillin allergy should not receive a first-generation cephalosporin without allergy assessment; later-generation cephalosporins are often tolerated.

Severe Cutaneous Adverse Reactions (SCARs)

Three SCARs are exam-critical:

Reaction Hallmarks Mortality

Stevens-Johnson syndrome (SJS) <10% body surface area skin detachment; target lesions; mucosal involvement (oral, conjunctival, urogenital) ~5–10%

Toxic epidermal necrolysis (TEN) >30% BSA detachment; full-thickness epidermal necrosis; SJS-TEN overlap = 10–30% BSA ~25–35%

DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Rash, fever, eosinophilia , lymphadenopathy, liver injury; onset 2–8 weeks after drug start ~10%

Red Flags That Demand Immediate Action

Mucosal involvement : oral blisters, painful swallowing, conjunctivitis, genital ulceration.

Skin blistering or peeling : positive Nikolsky sign (epidermis shears with lateral pressure).

Eosinophilia with organ involvement (liver, kidney, lung): think DRESS.

Rapid progression , fever, facial oedema.

The pharmacist's response to any suspected SCAR is: stop the suspected drug immediately, document, and refer the patient for urgent medical assessment — never re-challenge, never taper. Common culprit drugs (sulfonamides, allopurinol, carbamazepine, lamotrigine, phenytoin, nevirapine) should be flagged on the patient's profile for life.

Anaphylaxis

Anaphylaxis is a severe, life-threatening Type I hypersensitivity reaction with rapid onset. Diagnostic criteria include skin/mucosal change PLUS respiratory compromise OR hypotension OR gastrointestinal symptoms after a known allergen.

First-Line Treatment

Adrenaline (epinephrine) IM 0.5 mg (0.5 mL of 1:1000) in the anterolateral thigh for adults. Repeat every 5 minutes if no response.

NOT IV adrenaline in the first instance; IV adrenaline is reserved for refractory anaphylaxis in a monitored setting.

Airway, oxygen, IV fluid resuscitation; lay the patient flat with legs raised (not sitting up).

Adjuncts: antihistamine (e.g. chlorphenamine), corticosteroid (e.g. hydrocortisone 200 mg IV) — these are second-line and do not replace adrenaline.

After stabilisation: observe for biphasic reaction for at least 6–12 hours; consider an adrenaline auto-injector for discharge and an allergy referral.

A common exam trap asks which drug is first-line for anaphylaxis — the answer is always IM adrenaline . Antihistamines and steroids are adjuncts; they will not abort anaphylaxis. A second trap offers IV adrenaline as the first-line option — this is wrong for initial treatment; IV adrenaline is reserved for refractory anaphylaxis in a monitored setting because dosing errors and arrhythmias are common. A third trap asks where to inject — the anterolateral thigh (vastus lateralis) gives the fastest rise in plasma concentration; subcutaneous injection is slower and not recommended in acute anaphylaxis.